Navigation Links
Bluestar Silicones Presents Elastomer Solutions At Medical Design And Manufacturing (MD&M) East Show
Date:6/13/2013

PHILADELPHIA, June 13, 2013 /PRNewswire/ -- Bluestar Silicones will showcase its new Silbione® silicone elastomer solutions, including low durometer liquid silicone rubber (LSR) and self-bleeding LSR, at the upcoming Medical Design & Manufacturing (MD&M) East Conference (Booth #3744), June 18-20.  

Bluestar Silicones' new 1 Shore A (ShA) hardness product, Silbione LSR 4301, uniquely combines strong physical properties and easy processing in a low-durometer material. This product rounds out the company's 5 and 10 ShA soft LSR range, delivering high tear strength and elongation for soft cushioning and vibration dampening applications.

The company also introduces its new Silbione LSR 4755, which creates a lubricious surface on the molded part after vulcanization.  This lubricious material is designed to minimize friction and prevent slit healing in application.  Built into the bulk LSR formulation, the self bleeding lubricity of Silbione LSR 4755 eliminates the need for a secondary coating process to reduce coefficient of friction, reducing costs and improving cycle time for the part manufacturer.

"Bluestar Silicones is excited to present these specialty silicone solutions to the market," according to Karen O'Keefe, market manager, North America.  "The high performance physicals of our low durometer LSRs are unmatched in the industry.  And, our self-bleeding material provides a solution to the inherent non-slip surface of LSRs, improving productivity in automated assembly and part performance in select applications."

These specialty LSR products are manufactured in a clean room environment at Bluestar Silicones' new 226,000-sq-ft facility in York, S.C., and incorporate the distinctive advantages of Bluestar Silicones' standard LSR product line, including easy processing, easy release, and high-performance physical properties.

Bluestar Silicones also offers antimicrobial capability for OEMs and processors, which can be incorporated into its standard silicone products, providing a tailored material solution to meet specific healthcare requirements.

In addition to Bluestar Silicones' full line of LSR, the company offers high consistency rubbers (HCR), room-temperature vulcanized silicones (RTVs), skin adhesive tacky gels, cushioning gels and permanent adhesives for the healthcare market.  For more information, call (866) 474-6342.

About Bluestar Silicones

With worldwide operations headquartered in Lyon, France, Bluestar Silicones is a $650 million worldwide silicones raw material manufacturer. The company is one of the world's leading fully integrated global silicones manufacturers with more than 60 years of silicone expertise. Bluestar Silicones has manufacturing operations throughout the world and combines upstream silicon metal operations and capacity with downstream silicone market and application development expertise. The company offers a comprehensive range of silicone technologies in support of diverse specialty markets including paper release, textile coatings, healthcare, moldmaking, automotive, aerospace, and personal care. For more information, call (866) 474-6342.

Press Contact: Karen O'Keefe
Email: Karen.okeefe@bluestarsilicones.com


'/>"/>
SOURCE Bluestar Silicones
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Discovery Labs Presents Final Assessment in a Series of Pharmacoeconomic Analyses that Explore Impact of Reintubation on Healthcare Costs
2. Vanda Presents Data From Tasimelteon Phase III Studies In Non-24-Hour Disorder
3. Molly Fletcher to Speak at Astellas Presents Executive Womens Day at the FedEx St. Jude Classic
4. Nektar Presents Positive Preclinical Data for NKTR-214, a Novel Cancer Immunotherapy, At the 2013 American Society of Clinical Oncology Annual Meeting
5. NewLink Genetics Presents Results from Two Phase 1 Studies with Immunotherapy Agent, Indoximod, at the ASCO 2013 Annual Meeting
6. DelMar Pharmaceuticals Presents Additional Clinical Data from Ongoing Brain Cancer Study at ASCO
7. Nektar Presents Target-Specific Biomarkers Being Assessed in Ongoing Phase 3 BEACON Study of Etirinotecan Pegol for the Treatment of Metastatic Breast Cancer at the 2013 American Society of Clinical Oncology Annual Meeting
8. NewLink Genetics Presents Positive Phase 2 Data on Novel Immunotherapy, Tergenpumatucel-L, in Non-Small Cell Lung Cancer at the ASCO 2013 Annual Meeting
9. Amgen Presents Positive Results From Talimogene Laherparepvec Phase 3 Study In Patients With Metastatic Melanoma
10. BioElectronics Presents FDA Reclassification Panel
11. Boehringer Ingelheim Presents Progression-Free Survival Data for Investigational Afatinib and Nintedanib in Advanced NSCLC
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/4/2016)... , Feb. 4, 2016 In response to the ... FDA,s Deputy Commissioner for Medical Products and Tobacco, along with ... reassess the agency,s approach to opioid medications. The plan will ... providing patients in pain access to effective relief. ... , Re-examine the risk-benefit paradigm for opioids and ...
(Date:2/4/2016)...  Blueprint Medicines Corporation (NASDAQ: BPMC ), ... investigational kinase medicines for patients with genomically defined ... of directors of Lonnel Coats , a ... industry-related experience. Jeffrey Albers , ... strategic experience developing and commercializing numerous oncology products ...
(Date:2/4/2016)... SIOUX FALLS, S.D. , Feb. 4, 2016 ... patient and guest technology solutions, today announced that ... SONIFI Health Senior Living Engagement System. The system ... information tool that residents access through a tablet ... --> The resident engagement system provides access ...
Breaking Medicine Technology:
(Date:2/7/2016)... Orion, Clarkston, Metamora, Michigan (PRWEB) , ... February 07, 2016 , ... ... Friday in recognition of National Wear Red Day. National Wear Red Day is ... and stroke in women. Heart disease and stroke cause 1 in 3 deaths among ...
(Date:2/6/2016)... ... February 06, 2016 , ... ... ADVISORY: 5000 PERIOPERATIVE NURSES EXPECTED AT AORN SURGICAL CONFERENCE & EXPO , ... the world with an estimated 5000 perioperative nurses in attendance to study ...
(Date:2/6/2016)... ... February 06, 2016 , ... Shark Finds and Kevin ... of a new DRTV campaign with Belly Bands. , Having a dog is great—except ... to puppy pads and find nothing works, get Belly Bands, the easiest way ...
(Date:2/5/2016)... ... 05, 2016 , ... Love is in the air at King Kullen! The ... and packaging. This staple for Valentine’s Day is a must-have, and can be picked ... Day, not only are long-stem roses available, but also other flower bouquets, elegantly wrapped ...
(Date:2/5/2016)... , ... February 05, 2016 , ... ... setting the stage for new clinical and scientific initiatives have all marked the ... she was appointed President and CEO of the nation’s oldest cancer center, Candace ...
Breaking Medicine News(10 mins):